Pulmonary hypertension (PH) has a high mortality rate if untreated. Unfortunately, the disease is not consistently diagnosed or treated across the United States. To improve the diagnosis and care of ...

Early diagnosis of pulmonary arterial hypertension improves five-year survival by 42%, compared with delayed diagnosis, a ...

Pulmonary hypertension life expectancy and prognosis can vary broadly, but have improved in the era of modern treatment.

BARCELONA, Spain—New guidelines for the diagnosis and treatment of pulmonary hypertension (PH), released at the recent European Society of Cardiology (ESC) Congress 2022, include a new hemodynamic ...

New European Society of Cardiology (ESC)/European Respiratory Society (ERS) guidelines for diagnosis and treatment of pulmonary hypertension have lowered the cutoff for defining pulmonary hypertension ...

In treatment-naïve patients with PAH, initial monotherapy improves exercise capacity, hemodynamics, and outcomes when compared with those noted among untreated patients. In patients who are newly ...

Please provide your email address to receive an email when new articles are posted on . A systemic sclerosis-related pulmonary hypertension diagnosis in the last 10 years vs. 10 years prior was linked ...

Although more women than men have pulmonary arterial hypertension, several PAH medications are teratogenic, according to a ...

In ‘Made in SG’ Melanie Oliveiro profiles the locally founded Pulmonary Hypertension Support Group (PHSG), a patient support ...